Dagger
Anthony Dagger, Heslington GB
Patent application number | Description | Published |
---|---|---|
20100143435 | SCAFFOLD WITH INCREASED PORE SIZE - The invention relates to scaffolds for use as medical devices, for guided tissue regeneration and repair, wherein the relationship between fibre diameter and pore size in a scaffold is decoupled, thereby enabling the small fibre diameters required for cell attachment and proliferation and the large pore sizes needed for cell migration into the scaffold to be achieved. | 06-10-2010 |
20100324605 | POLYMER COMPOSITIONS AND DEVICES - High strength bioresorbable polymers suitable for orthopaedic applications comprising sulphonyl diphenol, hydroxybenzoic acid and dicarboxylic acid. | 12-23-2010 |
Anthony Dagger, York GB
Patent application number | Description | Published |
---|---|---|
20100297208 | SCAFFOLD - The present invention relates to scaffolds which can be used as medical devices for guided tissue regeneration and repair, in particular the invention is directed to a scaffold comprising fibres having a mean fibre diameter of between from about 1.2 to 4.0 microns, wherein the fibres comprise a glycolide. The invention further relates to the use of the scaffolds for the selective capture of cell populations for a cell source material. | 11-25-2010 |
Anthony C. Dagger, York GB
Patent application number | Description | Published |
---|---|---|
20150150729 | DEVICES AND METHODS FOR TREATING AND CLOSING WOUNDS WITH NEGATIVE PRESSURE - The present invention relates to a negative pressure wound closure system and methods for using such a system. Preferred embodiments of the invention facilitate closure of the wound by preferentially contracting to provide for movement of the tissue. | 06-04-2015 |
Dean Frederick Dagger, Balderstone Lancs GB
Patent application number | Description | Published |
---|---|---|
20100042242 | SKIN DESIGN PROCESS - A method of designing a virtual model for the manufacture of a blended body structure having two or more constituent elements, the method comprising the step of defining a parameterised, theoretical procedural skin from which two or more datum skins are generated, each datum skin defining a production outline of an airframe structure constituent element. The use of a procedural model with embedded parameterisation and associativity to derive the datum skins reduces the time taken to produce the datum skins and enables feature modifications to be incorporated into models quickly and consistently. | 02-18-2010 |
Raymond Dagger, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20100228039 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS - Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N′-bis(3,5-di-t-butyl-salicylidene) and RuCl | 09-09-2010 |
20120149906 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS - Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N′-bis(3,5-di-t-butyl-salicylidene) and RuCl | 06-14-2012 |
20130023662 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS - Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N′-bis(3,5-di-t-butyl-salicylidene) and RuCl | 01-24-2013 |
Raymond E. Dagger, Mount Airy, MD US
Patent application number | Description | Published |
---|---|---|
20110189297 | STABLE SOLID ORAL DOSAGE CO-FORMULATIONS - Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics of drugs that undergo in vivo degradation by cytochrome P450 enzymes. Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Specifically, methods of inhibiting metabolic degradation of atazanavir sulphate for administering to a patient suffering from HIV infection are disclosed. | 08-04-2011 |
Robert K. Dagger, Shipbourne GB
Patent application number | Description | Published |
---|---|---|
20080295437 | Attachment system for a modular flooring assembly - A modular flooring assembly, includes at least two floor members, each including top and bottom portions, and edge portions configured for operative engagement with the edge portion of an adjacent floor member to form a common joint, wherein the engaged edge portions are further configured for facilitating radial movement of the juxtaposed floor members about the common joint, a resilient, elastic material supporting the bottom portion of the floor members in contact with the ground, and an attachment system including clip with a cross-piece member having first and second ends, a pair of opposed legs, each extending from the corresponding first and second ends inwardly toward one another, and the legs each configured for operatively engaging the top portions of corresponding one of adjacent floor members to securely retain the engaged floor members in juxtaposition and prevent lateral separation, while permitting radial movement of the adjacent floor members about their common joint. | 12-04-2008 |